| Q8V | Name: | ethyl (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate | Formula: | C12 H12 N2 O2 | SMILES: | c1cc(C(=C(C(OCC)=O)C#N)N)ccc1 | InChi: | InChI=1S/C12H12N2O2/c1-2-16-12(15)10(8-13)11(14)9-6-4-3-5-7-9/h3-7H,2,14H2,1H3/b11-10- | Synonyms: | phenamacril | Definition date: | 2019-10-03 | Last modified: | 2021-03-01 | Release date: | 2020-03-25 | Identifier: | ethyl (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate |
|
| 98M | Name: | 6-{[3-chloro-4-(4-methylpiperazin-1-yl)phenyl]amino}-1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one | Formula: | C27 H31 Cl N8 O2 | SMILES: | c1(nc(ccc1)N2N(C(=O)c3c2nc(nc3)Nc5cc(Cl)c(N4CCN(CC4)C)cc5)CC=C)C(O)(C)C | InChi: | InChI=1S/C27H31ClN8O2/c1-5-11-35-25(37)19-17-29-26(32-24(19)36(35)23-8-6-7-22(31-23)27(2,3)38)30-18-9-10-21(20(28)16-18)34-14-12-33(4)13-15-34/h5-10,16-17,38H,1,11-15H2,2-4H3,(H,29,30,32) | Synonyms: | RAC-IV-099 | Definition date: | 2017-04-09 | Last modified: | 2021-03-01 | Release date: | 2018-04-04 | Identifier: | 6-{[3-chloro-4-(4-methylpiperazin-1-yl)phenyl]amino}-1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one |
|
| 991 | Name: | 2-{5-[AMINO(IMINIO)METHYL]-6-CHLORO-1H-INDOL-2-YL}-6-(CYCLOPENTYLOXY)BENZENOLATE | Formula: | C20 H20 Cl N3 O2 | SMILES: | [O-]c4c(OC1CCCC1)cccc4c3cc2cc(c(Cl)cc2n3)C(=[NH2+])N | InChi: | InChI=1S/C20H20ClN3O2/c21-15-10-16-11(8-14(15)20(22)23)9-17(24-16)13-6-3-7-18(19(13)25)26-12-4-1-2-5-12/h3,6-10,12,24-25H,1-2,4-5H2,(H3,22,23) | Synonyms: | CRA_10991 | Definition date: | 2003-03-14 | Last modified: | 2021-03-01 | Identifier: | 2-{5-[amino(iminio)methyl]-6-chloro-1H-indol-2-yl}-6-(cyclopentyloxy)phenolate |
|
| 99J | Name: | 6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1-{6-[(1S)-2,2,2-trifluoro-1-hydroxyethyl]pyridin-2-yl}-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one | Formula: | C26 H27 F3 N8 O2 | SMILES: | c5c(Nc2ncc1C(=O)N(CC=C)N(c1n2)c3nc(ccc3)C(O)C(F)(F)F)ccc(N4CCN(C)CC4)c5 | InChi: | InChI=1S/C26H27F3N8O2/c1-3-11-36-24(39)19-16-30-25(31-17-7-9-18(10-8-17)35-14-12-34(2)13-15-35)33-23(19)37(36)21-6-4-5-20(32-21)22(38)26(27,28)29/h3-10,16,22,38H,1,11-15H2,2H3,(H,30,31,33)/t22-/m0/s1 | Synonyms: | RAC-IV-016 | Definition date: | 2017-04-11 | Last modified: | 2021-03-01 | Release date: | 2018-04-04 | Identifier: | 6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1-{6-[(1S)-2,2,2-trifluoro-1-hydroxyethyl]pyridin-2-yl}-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one |
|
| RHP | Name: | (3R)-3-(PROP-2-YNYLAMINO)INDAN-5-OL | Formula: | C12 H13 N O | SMILES: | Oc1ccc2c(c1)C(NCC#C)CC2 | InChi: | InChI=1S/C12H13NO/c1-2-7-13-12-6-4-9-3-5-10(14)8-11(9)12/h1,3,5,8,12-14H,4,6-7H2/t12-/m1/s1 | Synonyms: | 5-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN | Definition date: | 2004-01-15 | Last modified: | 2021-03-01 | Identifier: | (3R)-3-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-5-ol |
|
| 9B4 | Name: | (2R,5R,13R,16R)-9-(hydroxymethyl)-9-{[(2R)-2-hydroxypropoxy]methyl}-5,13-dimethyl-4,7,11,14-tetraoxaheptadecane-2,16-diol | Formula: | C20 H42 O9 | SMILES: | CC(COCC(CO)(COCC(C)O)COCC(OCC(O)C)C)OCC(O)C | InChi: | InChI=1S/C20H42O9/c1-15(22)6-25-12-20(11-21,13-26-9-18(4)28-7-16(2)23)14-27-10-19(5)29-8-17(3)24/h15-19,21-24H,6-14H2,1-5H3/t15-,16-,17-,18-,19-/m1/s1 | Synonyms: | Pentaerythritol propoxylate (5/4 PO/OH) | Definition date: | 2017-04-14 | Last modified: | 2021-03-01 | Release date: | 2017-10-25 | Identifier: | (2R,5R,13R,16R)-9-(hydroxymethyl)-9-{[(2R)-2-hydroxypropoxy]methyl}-5,13-dimethyl-4,7,11,14-tetraoxaheptadecane-2,16-diol |
|
| RIM | Name: | RIMANTADINE | Formula: | C12 H21 N | SMILES: | NC(C)C13CC2CC(CC(C1)C2)C3 | InChi: | InChI=1S/C12H21N/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12/h8-11H,2-7,13H2,1H3/t8-,9-,10+,11-,12-/m1/s1 | Synonyms: | 1-(1-ADAMANTYL)ETHANAMINE | Definition date: | 2007-07-19 | Last modified: | 2021-03-01 | Identifier: | (1R)-1-[(3S,5S,7S)-tricyclo[3.3.1.1~3,7~]dec-1-yl]ethanamine |
|
| RIT | Name: | RITONAVIR | Formula: | C37 H48 N6 O5 S2 | SMILES: | O=C(OCc1scnc1)NC(Cc2ccccc2)C(O)CC(NC(=O)C(NC(=O)N(Cc3nc(sc3)C(C)C)C)C(C)C)Cc4ccccc4 | InChi: | InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1 | Synonyms: | A-84538 | Definition date: | 1999-07-08 | Last modified: | 2021-03-01 | Identifier: | N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide |
|
| RIV | Name: | 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide | Formula: | C19 H18 Cl N3 O5 S | SMILES: | O=C(NCC3OC(=O)N(c2ccc(N1C(=O)COCC1)cc2)C3)c4sc(Cl)cc4 | InChi: | InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1 | Synonyms: | Rivaroxaban | Definition date: | 2008-10-24 | Last modified: | 2021-03-01 | Identifier: | 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide |
|
| RJ1 | Name: | N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide | Formula: | C9 H9 Cl F3 N5 | SMILES: | Clc1ccc(cc1NC(=[N@H])NC(=[N@H])N)C(F)(F)F | InChi: | InChI=1S/C9H9ClF3N5/c10-5-2-1-4(9(11,12)13)3-6(5)17-8(16)18-7(14)15/h1-3H,(H6,14,15,16,17,18) | Synonyms: | 2-{[{[amino(imino)methyl]amino}(imino)methyl]amino}-1-chloro-4-(trifluoromethyl)benzene | Definition date: | 2008-06-17 | Last modified: | 2021-03-01 | Identifier: | N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide |
|
| 9BZ | Name: | (3~{R},5~{R},7~{a}~{S})-2,2-dimethyl-5-(sulfanylmethyl)-3,5,7,7~{a}-tetrahydro-[1,3]thiazolo[4,3-b][1,3]thiazole-3-carboxylic acid | Formula: | C9 H15 N O2 S3 | SMILES: | CC1(C)S[CH]2CS[CH](CS)N2[CH]1C(O)=O | InChi: | InChI=1S/C9H15NO2S3/c1-9(2)7(8(11)12)10-5(3-13)14-4-6(10)15-9/h5-7,13H,3-4H2,1-2H3,(H,11,12)/t5-,6+,7-/m1/s1 | Synonyms: | L-VC26 | Definition date: | 2015-11-20 | Last modified: | 2021-03-01 | Release date: | 2016-06-01 | Identifier: | (3~{R},5~{R},7~{a}~{S})-2,2-dimethyl-5-(sulfanylmethyl)-3,5,7,7~{a}-tetrahydro-[1,3]thiazolo[4,3-b][1,3]thiazole-3-carboxylic acid |
|
| RKE | Name: | (R)-ketamine | Formula: | C13 H16 Cl N O | SMILES: | Clc1c(cccc1)C2(NC)C(=O)CCCC2 | InChi: | InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m1/s1 | Synonyms: | (2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone | Definition date: | 2011-05-02 | Last modified: | 2021-03-01 | Release date: | 2012-08-24 | Identifier: | (2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone |
|
| 9D9 | Name: | [5-(2-amino-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)-1,1-difluoropentyl]phosphonic acid | Formula: | C11 H15 F2 N4 O4 P | SMILES: | OP(O)(=O)C(CCCCc1c2c(nc1)C(NC(=N2)N)=O)(F)F | InChi: | InChI=1S/C11H15F2N4O4P/c12-11(13,22(19,20)21)4-2-1-3-6-5-15-8-7(6)16-10(14)17-9(8)18/h5,15H,1-4H2,(H2,19,20,21)(H3,14,16,17,18) | Synonyms: | DFPP-DG | Definition date: | 2009-02-09 | Last modified: | 2021-03-01 | Identifier: | [5-(2-amino-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)-1,1-difluoropentyl]phosphonic acid |
|
| RMA | Name: | N-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YL]-N-METHYL-N-PROP-2-YNYLAMINE | Formula: | C13 H15 N | SMILES: | C#CCN(C)C2c1ccccc1CC2 | InChi: | InChI=1S/C13H15N/c1-3-10-14(2)13-9-8-11-6-4-5-7-12(11)13/h1,4-7,13H,8-10H2,2H3/t13-/m1/s1 | Synonyms: | N-METHYL-N-PROPARGYL-1(R)-AMINOINDAN | Definition date: | 2004-01-15 | Last modified: | 2021-03-01 | Identifier: | (1R)-N-methyl-N-prop-2-yn-1-yl-2,3-dihydro-1H-inden-1-amine |
|
| 9FR | Name: | (6aS,8aR,12aS,12bR,13aR)-5,6a,9,9,12a,13a-hexamethyl-7,8,8a,9,11,12,12a,12b,13,13a-decahydro-3H-benzo[a]furo[3,4-j]xanthene-3,4,10(1H,6aH)-trione | Formula: | C25 H32 O5 | SMILES: | C5(CCC4(C3C(OC=2C(C1=C(C(=O)OC1)C(C=2C)=O)(C)C3)(C)CCC4C5(C)C)C)=O | InChi: | InChI=1S/C25H32O5/c1-13-19(27)18-14(12-29-21(18)28)24(5)11-16-23(4)9-8-17(26)22(2,3)15(23)7-10-25(16,6)30-20(13)24/h15-16H,7-12H2,1-6H3/t15-,16+,23-,24+,25-/m0/s1 | Synonyms: | Preandiloid B | Definition date: | 2018-04-11 | Last modified: | 2021-03-01 | Release date: | 2018-07-18 | Identifier: | (6aS,8aR,12aS,12bR,13aR)-5,6a,9,9,12a,13a-hexamethyl-7,8,8a,9,11,12,12a,12b,13,13a-decahydro-3H-benzo[a]furo[3,4-j]xanthene-3,4,10(1H,6aH)-trione |
|
| 9FU | Name: | (6aS,8aR,12aS,12bR,13aR)-5,6a,9,9,12a,13a-hexamethyl-7,8,8a,9,12a,12b,13,13a-octahydro-3H-benzo[a]furo[3,4-j]xanthene-3,4,10(1H,6aH)-trione | Formula: | C25 H30 O5 | SMILES: | C1(=O)C=CC2(C(C1(C)C)CCC5(C)C2CC4(C3=C(C(OC3)=O)C(C(=C4O5)C)=O)C)C | InChi: | InChI=1S/C25H30O5/c1-13-19(27)18-14(12-29-21(18)28)24(5)11-16-23(4)9-8-17(26)22(2,3)15(23)7-10-25(16,6)30-20(13)24/h8-9,15-16H,7,10-12H2,1-6H3/t15-,16+,23-,24+,25-/m0/s1 | Synonyms: | Preandiloid C | Definition date: | 2018-04-11 | Last modified: | 2021-03-01 | Release date: | 2018-07-18 | Identifier: | (6aS,8aR,12aS,12bR,13aR)-5,6a,9,9,12a,13a-hexamethyl-7,8,8a,9,12a,12b,13,13a-octahydro-3H-benzo[a]furo[3,4-j]xanthene-3,4,10(1H,6aH)-trione |
|
| RNH | Name: | (2R)-N-[3-(heptylamino)-3-oxopropyl]-2,4-dihydroxy-3,3-dimethylbutanamide | Formula: | C16 H32 N2 O4 | SMILES: | O=C(NCCC(=O)NCCCCCCC)C(O)C(C)(C)CO | InChi: | InChI=1S/C16H32N2O4/c1-4-5-6-7-8-10-17-13(20)9-11-18-15(22)14(21)16(2,3)12-19/h14,19,21H,4-12H2,1-3H3,(H,17,20)(H,18,22)/t14-/m0/s1 | Synonyms: | N-heptylpantothenamide | Definition date: | 2011-07-05 | Last modified: | 2021-03-01 | Identifier: | (2R)-N-[3-(heptylamino)-3-oxopropyl]-2,4-dihydroxy-3,3-dimethylbutanamide |
|
| 9G9 | Name: | 5,5'-[(2R,3S)-2,3-dimethylbutane-1,4-diyl]bis(2H-1,3-benzodioxole) | Formula: | C20 H22 O4 | SMILES: | O3c4cc(CC(C)C(Cc2cc1OCOc1cc2)C)ccc4OC3 | InChi: | InChI=1S/C20H22O4/c1-13(7-15-3-5-17-19(9-15)23-11-21-17)14(2)8-16-4-6-18-20(10-16)24-12-22-18/h3-6,9-10,13-14H,7-8,11-12H2,1-2H3/t13-,14+ | Synonyms: | Machilin A | Definition date: | 2018-04-17 | Last modified: | 2021-03-01 | Release date: | 2019-07-24 | Identifier: | 5,5'-[(2R,3S)-2,3-dimethylbutane-1,4-diyl]bis(2H-1,3-benzodioxole) |
|
| ROF | Name: | 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE | Formula: | C17 H14 Cl2 F2 N2 O3 | SMILES: | Clc3c(NC(=O)c2ccc(OC(F)F)c(OCC1CC1)c2)c(Cl)cnc3 | InChi: | InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24) | Synonyms: | ROFLUMILAST | Definition date: | 2004-11-16 | Last modified: | 2021-03-01 | Identifier: | 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide |
|
| ROS | Name: | N,N'-TETRAMETHYL-ROSAMINE | Formula: | C23 H23 N2 O | SMILES: | O2c1cc(ccc1C(=C3C2=CC(=[N+](/C)C)C=C3)c4ccccc4)N(C)C | InChi: | InChI=1S/C23H23N2O/c1-24(2)17-10-12-19-21(14-17)26-22-15-18(25(3)4)11-13-20(22)23(19)16-8-6-5-7-9-16/h5-15H,1-4H3/q+1 | Synonyms: | (6-DIMETHYLAMINO-9-PHENYL-XANTHEN-3-YLIDENE)-DIMETHYL-AMMONIUM | Definition date: | 2000-05-22 | Last modified: | 2021-03-01 | Identifier: | N-[6-(dimethylamino)-9-phenyl-3H-xanthen-3-ylidene]-N-methylmethanaminium |
|
| RPG | Name: | (13E,15S)-15-hydroxy-9-oxoprosta-10,13-dien-1-oic acid | Formula: | C20 H32 O4 | SMILES: | CCCCC[CH](O)C=C[CH]1C=CC(=O)[CH]1CCCCCCC(O)=O | InChi: | InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12-18,21H,2-11H2,1H3,(H,23,24)/b14-12+/t16-,17-,18+/m0/s1 | Synonyms: | PROSTAGLANDIN A1 (PGA1) | Definition date: | 2017-08-17 | Last modified: | 2021-03-01 | Release date: | 2018-12-26 | Identifier: | 7-[(1~{R},5~{S})-2-oxidanylidene-5-[(~{E},3~{S})-3-oxidanyloct-1-enyl]cyclopent-3-en-1-yl]heptanoic acid |
|
| RPR | Name: | 3-[(3'-AMINOMETHYL-BIPHENYL-4-CARBONYL)-AMINO]-2-(3-CARBAMIMIDOYL-BENZYL)-BUTYRIC ACID METHYL ESTER | Formula: | C27 H30 N4 O3 | SMILES: | O=C(OC)C(Cc1cc(C(=[N@H])N)ccc1)C(NC(=O)c3ccc(c2cccc(c2)CN)cc3)C | InChi: | InChI=1S/C27H30N4O3/c1-17(24(27(33)34-2)15-18-5-3-8-23(13-18)25(29)30)31-26(32)21-11-9-20(10-12-21)22-7-4-6-19(14-22)16-28/h3-14,17,24H,15-16,28H2,1-2H3,(H3,29,30)(H,31,32)/t17-,24-/m1/s1 | Synonyms: | RPR128515 | Definition date: | 2000-05-22 | Last modified: | 2021-03-01 | Identifier: | methyl (2R,3R)-3-({[3'-(aminomethyl)biphenyl-4-yl]carbonyl}amino)-2-(3-carbamimidoylbenzyl)butanoate |
|
| 9J6 | Name: | 6-ethoxy-6-oxohexanoic acid | Formula: | C8 H14 O4 | SMILES: | O=C(O)CCCCC(=O)OCC | InChi: | InChI=1S/C8H14O4/c1-2-12-8(11)6-4-3-5-7(9)10/h2-6H2,1H3,(H,9,10) | Synonyms: | Adipic acid monoethyl ester | Definition date: | 2018-05-02 | Last modified: | 2021-03-01 | Release date: | 2018-09-12 | Identifier: | 6-ethoxy-6-oxohexanoic acid |
|
| 9J7 | Name: | 1-(2,3-difluoro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide | Formula: | C20 H22 F2 N2 O3 S | SMILES: | c1(c(c(F)c(C)cc1)F)CS(Nc3cc2CCC(N(CCC)c2cc3)=O)(=O)=O | InChi: | InChI=1S/C20H22F2N2O3S/c1-3-10-24-17-8-7-16(11-14(17)6-9-18(24)25)23-28(26,27)12-15-5-4-13(2)19(21)20(15)22/h4-5,7-8,11,23H,3,6,9-10,12H2,1-2H3 | Synonyms: | AMF2alpha | Definition date: | 2017-05-15 | Last modified: | 2021-03-01 | Release date: | 2017-11-15 | Identifier: | 1-(2,3-difluoro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide |
|
| RR1 | Name: | 5-(4,6-DIAMINO-[1,3,5]TRIAZIN-2-YLAMINO)-4-HYDROXY-3-(2-SULFO-PHENYLAZO)-NAPHTHALENE-2,7-DISULFONIC ACID | Formula: | C19 H16 N8 O10 S3 | SMILES: | O=S(=O)(O)c4ccccc4/N=N/c2c(O)c1c(cc(cc1cc2S(=O)(=O)O)S(=O)(=O)O)Nc3nc(nc(n3)N)N | InChi: | InChI=1S/C19H16N8O10S3/c20-17-23-18(21)25-19(24-17)22-11-7-9(38(29,30)31)5-8-6-13(40(35,36)37)15(16(28)14(8)11)27-26-10-3-1-2-4-12(10)39(32,33)34/h1-7,28H,(H,29,30,31)(H,32,33,34)(H,35,36,37)(H5,20,21,22,23,24,25)/b27-26+ | Synonyms: | REACTIVE RED 1 DYE | Definition date: | 2001-03-07 | Last modified: | 2021-03-01 | Identifier: | 5-[(4,6-diamino-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(E)-(2-sulfophenyl)diazenyl]naphthalene-2,7-disulfonic acid |
|